Previous studies confirmed the role of bone marrow-originated Cd34-derived myeloid cells in cardiovascular diseases, which is a distinct developmental origin from their tissue-resident mesenchymal cells and EC counterparts [13]. This evidence concerns the gene CD34 and cardiovascular disorder.